Home

Vorbi Respect de sine capitol carta 2003 levodopa gad rochie Stabilițivă fior

Levodopa-Induced Dyskinesia in Parkinson's Disease
Levodopa-Induced Dyskinesia in Parkinson's Disease

Entacapone potentiates the long-duration response but does not normalize  levodopa-induced molecular changes - ScienceDirect
Entacapone potentiates the long-duration response but does not normalize levodopa-induced molecular changes - ScienceDirect

PDF) A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra  Pars Compacta in Parkinson's Disease
PDF) A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's Disease

Parkinson's Disease Therapeutics: New Developments and Challenges Since the  Introduction of Levodopa | Neuropsychopharmacology
Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa | Neuropsychopharmacology

Frontiers | Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of  Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced  Dyskinesia
Frontiers | Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia

β-asarone and levodopa coadministration increases striatal levels of  dopamine and levodopa and improves behavioral competence in Parkinson's rat  by enhancing dopa decarboxylase activity - ScienceDirect
β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity - ScienceDirect

Vista de Biosíntesis de la morfina: su importancia en la enfermedad de  Parkinson | Revista de la Facultad de Medicina
Vista de Biosíntesis de la morfina: su importancia en la enfermedad de Parkinson | Revista de la Facultad de Medicina

Anxiety: An ignored aspect of Parkinson's disease lacking attention -  ScienceDirect
Anxiety: An ignored aspect of Parkinson's disease lacking attention - ScienceDirect

The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson's Disease |  Pharmacological Reviews
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson's Disease | Pharmacological Reviews

Concomitant short‐ and long‐duration response to levodopa in the  6‐OHDA‐lesioned rat: a behavioural and molecular study - Marin - 2007 -  European Journal of Neuroscience - Wiley Online Library
Concomitant short‐ and long‐duration response to levodopa in the 6‐OHDA‐lesioned rat: a behavioural and molecular study - Marin - 2007 - European Journal of Neuroscience - Wiley Online Library

Anxiety: An ignored aspect of Parkinson's disease lacking attention -  ScienceDirect
Anxiety: An ignored aspect of Parkinson's disease lacking attention - ScienceDirect

µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's  Disease | Journal of Neuroscience
µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease | Journal of Neuroscience

Levodopa pharmacokinetics -from stomach to brain : A study on patients with  Parkinson's disease
Levodopa pharmacokinetics -from stomach to brain : A study on patients with Parkinson's disease

PDF) Serotonergic mechanisms responsible for levodopa-induced dyskinesias  in Parkinson's disease patients
PDF) Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients

Levodopa pharmacokinetics -from stomach to brain : A study on patients with  Parkinson's disease
Levodopa pharmacokinetics -from stomach to brain : A study on patients with Parkinson's disease

l‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and  astrocytes play a role? - Carta - 2017 - European Journal of Neuroscience -  Wiley Online Library
l‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role? - Carta - 2017 - European Journal of Neuroscience - Wiley Online Library

Cerebrospinal fluid levels of catecholamines and its metabolites in  Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced  dyskinesia - Andersen - 2017 - Journal of Neurochemistry - Wiley Online  Library
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia - Andersen - 2017 - Journal of Neurochemistry - Wiley Online Library

Signal transduction in l-DOPA-induced dyskinesia: from receptor  sensitization to abnormal gene expression | SpringerLink
Signal transduction in l-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression | SpringerLink

Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving  concepts - Espay - 2018 - Annals of Neurology - Wiley Online Library
Levodopa‐induced dyskinesia in Parkinson disease: Current and evolving concepts - Espay - 2018 - Annals of Neurology - Wiley Online Library

Frontiers | A Multi-Scale Computational Model of Levodopa-Induced Toxicity  in Parkinson's Disease
Frontiers | A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease

Levodopa pharmacokinetics -from stomach to brain : A study on patients with  Parkinson's disease
Levodopa pharmacokinetics -from stomach to brain : A study on patients with Parkinson's disease

PDF) A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra  Pars Compacta in Parkinson's Disease
PDF) A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's Disease

Anxiety: An ignored aspect of Parkinson's disease lacking attention -  ScienceDirect
Anxiety: An ignored aspect of Parkinson's disease lacking attention - ScienceDirect